Identification of novel biomarkers of prostate cancer through integrated analysis

Pu Zhang(Taian City Central Hospital), Yajun Xiao(Union Hospital), Yifei Xing(Union Hospital), Fang Lv(Liaoning Normal University), Bei Qian(Huazhong University of Science and Technology), Zijian Liu(Sichuan University), Decai Wang(North Sichuan Medical University)
Translational Andrology and Urology
August 1, 2021
10.21037/tau-21-401
Cited by 14

Related Papers

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
|Bone|2019|110
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles
|Medicine|2017|100